Tanabe Pharma Reports Promising Clinical Results for Dersimelagon in Rare Disorders EPP and XLP Tanabe Pharma America has shared exciting topline results from the INSPIRE study, confirming the efficacy of Dersimelagon for EPP and XLP patients.

Tanabe Pharma Reports Promising Clinical Results for Dersimelagon in Rare Disorders EPP and XLP #USA #Jersey_City #EPP #Dersimelagon #XLP